Agreed InToWin! And in all seriousness, you cannot compare two completely different Companies and how they will be judged by US investors.
PRR are at a critical stage in their development, are unique in their field (ovarian and other Muc-1 cancers)and this has not gone un-noticed by US and Australian media.
IMO, the Nasdaq listing will be timed to perfection!
last oppurtunity, page-16
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $1.339M | 4.459M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 70497 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 15625 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |